Literature DB >> 32034969

Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial.

L A Simmonds1, T R Sullivan1, M Skubisz1,2, P F Middleton1,3, K P Best1,3, L N Yelland1,4, J Quinlivan5, S J Zhou6, G Liu1,6, A J McPhee1,7, R A Gibson1,6, M Makrides1,3.   

Abstract

OBJECTIVE: To identify a polyunsaturated fatty acid (PUFA) biomarker able to detect which women with singleton pregnancies are most likely to benefit from omega-3 supplementation to reduce their risk of early preterm birth.
DESIGN: Exploratory analysis of a randomised controlled trial.
SETTING: Six Australian hospitals. POPULATION: Women with a singleton pregnancy enrolled in the ORIP trial.
METHODS: Using maternal capillary whole blood collected ~14 weeks' gestation, the fatty acids in total blood lipids were quantified using gas chromatography. Interaction tests examined whether baseline PUFA status modified the effect of omega-3 supplementation on birth outcomes. MAIN OUTCOME MEASURE: Early preterm birth (<34 weeks' gestation).
RESULTS: A low total omega-3 PUFA status in early pregnancy was associated with a higher risk of early preterm birth. Among women with a total omega-3 status ≤4.1% of total fatty acids, omega-3 supplementation substantially reduced the risk of early preterm birth compared with control (0.73 versus 3.16%; relative risk = 0.23, 95% confidence interval [CI] 0.07-0.79). Conversely, women with higher total omega-3 status in early pregnancy were at lower risk of early preterm birth. Supplementing women with a baseline status above 4.9% increased early preterm birth (2.20 versus 0.97%; relative risk = 2.27, 95% CI 1.13-4.58).
CONCLUSIONS: Women with singleton pregnancies and low total omega-3 PUFA status early in pregnancy have an increased risk of early preterm birth and are most likely to benefit from omega-3 supplementation to reduce this risk. Women with higher total omega-3 status are at lower risk and additional omega-3 supplementation may increase their risk. TWEETABLE ABSTRACT: Low total omega-3 fat status helps identify which women benefit from extra omega-3 to reduce early prematurity.
© 2020 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Biomarker; docosahexaenoic acid; omega-3 fatty acids; preterm birth

Mesh:

Substances:

Year:  2020        PMID: 32034969     DOI: 10.1111/1471-0528.16168

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  13 in total

1.  Fructooligosaccharides: From Breast Milk Components to Potential Supplements. A Systematic Review.

Authors:  Valentina De Cosmi; Alessandra Mazzocchi; Carlo Agostoni; Francesco Visioli
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

2.  DHA and Cognitive Development.

Authors:  Susan E Carlson; John Colombo
Journal:  J Nutr       Date:  2021-11-02       Impact factor: 4.687

3.  Fingertip Whole Blood as an Indicator of Omega-3 Long-Chain Polyunsaturated Fatty Acid Changes during Dose-Response Supplementation in Women: Comparison with Plasma and Erythrocyte Fatty Acids.

Authors:  Barbara J Meyer; Cassandra Sparkes; Andrew J Sinclair; Robert A Gibson; Paul L Else
Journal:  Nutrients       Date:  2021-04-23       Impact factor: 5.717

4.  Utility of a 7- question online screener for DHA intake.

Authors:  D N Christifano; S A Crawford; G Lee; B J Gajewski; S E Carlson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2022-01-08       Impact factor: 4.006

Review 5.  The Influence of Omega-3 Long-Chain Polyunsaturated Fatty Acid, Docosahexaenoic Acid, on Child Behavioral Functioning: A Review of Randomized Controlled Trials of DHA Supplementation in Pregnancy, the Neonatal Period and Infancy.

Authors:  Jacqueline F Gould; Rachel M Roberts; Maria Makrides
Journal:  Nutrients       Date:  2021-01-28       Impact factor: 5.717

6.  Effect of Omega-3 Supplementation in Pregnant Women with Obesity on Newborn Body Composition, Growth and Length of Gestation: A Randomized Controlled Pilot Study.

Authors:  Carmen Monthé-Drèze; Sarbattama Sen; Sylvie Hauguel-de Mouzon; Patrick M Catalano
Journal:  Nutrients       Date:  2021-02-09       Impact factor: 5.717

7.  Patient's experience with the Arabin cervical pessary during pregnancy: A questionnaire survey.

Authors:  Viola Seravalli; Noemi Strambi; Alessandra D'Arienzo; Francesco Magni; Ludovico Bernardi; Anna Morucchio; Mariarosaria Di Tommaso
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

8.  Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial.

Authors:  Susan E Carlson; Byron J Gajewski; Christina J Valentine; Elizabeth H Kerling; Carl P Weiner; Michael Cackovic; Catalin S Buhimschi; Lynette K Rogers; Scott A Sands; Alexandra R Brown; Dinesh Pal Mudaranthakam; Sarah A Crawford; Emily A DeFranco
Journal:  EClinicalMedicine       Date:  2021-05-17

Review 9.  Omega-3 Fatty Acids in Pregnancy-The Case for a Target Omega-3 Index.

Authors:  Clemens von Schacky
Journal:  Nutrients       Date:  2020-03-26       Impact factor: 5.717

10.  Fatty Acid Reference Intervals in Red Blood Cells among Pregnant Women in Norway-Cross Sectional Data from the 'Little in Norway' Cohort.

Authors:  Pedro Araujo; Marian Kjellevold; Ive Nerhus; Lisbeth Dahl; Inger Aakre; Vibeke Moe; Lars Smith; Maria Wik Markhus
Journal:  Nutrients       Date:  2020-09-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.